CTRI/2020/05/025242
Completed
未知
Population pharmacokinetics of hydroxychloroquine sulphate in healthcare workers given for prophylaxis against Corona Virus Disease 2019 (COVID 19) pandemic in India
Overview
- Phase
- 未知
- Status
- Completed
- Enrollment
- 158
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Asymptomatic Health Care workers (HCWs) of any gender and conditions as follows:
- •age 18 \-65 years (HCW who are actively on duty and not any who have retired) on prophylaxis with HCQ against COVID\-19 infection â?? Group 1 without comorbiditie
- •age 18 \-65 years (HCW who are actively on duty and not any who have retired) who are to be initiated on prophylaxis â?? Group 2 without comorbidities
- •age 18 \-65 years (HCW who are actively on duty and not any who have retired) on prophylaxis with HCQ against COVID\-19 infection with comorbidities (HT, Diabetes) â?? Group3
- •age 18 \-65 years (HCW who are actively on duty and not any who have retired) who are to be initiated on prophylaxis â?? Group 2 with comorbidities (HT, Diabetes)
Exclusion Criteria
- •Health care workers who show symptoms suggestive of COVID\-19 or are positive for COVID\-19
- •Women of child bearing potential who are not willing for adequate contraception during the time of blood collection / who were not practicing adequate contraception in the last 28 days
- •Women who are pregnant or breast feeding
- •Participants who are not determined to be fit by the investigator
- •Participants who are prescribed HCQ for any other indication / history of taking HCQ in the last one year
Investigators
Similar Trials
Recruiting
Phase 3
Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in patients with covid-19COVID-19.U07.1 - COVID-19COVID-19IRCT20200428047228N2Quality Improvement of Intensive Care Research Center- Shahid Beheshti University40
Active, not recruiting
Not Applicable
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
Completed
Not Applicable
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
Completed
Not Applicable
Effect of hydroxychloroquine on recurrent abortion treatmentrecurrent abortion.Spontaneous abortionIRCT2015120910664N2Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res60
Not yet recruiting
Phase 3
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.Health Condition 1: E050- Thyrotoxicosis with diffuse goiterCTRI/2023/07/054894IPQA laboratories